Evidence map›Paper›PMID 34681818›Full record

ArticleInternational journal of molecular sciences2021

HPV Lesions and Other Issues in the Oral Cavity Treatment and Removal without Pain.

Salima El Moussaoui, Mireia Mallandrich, Núria Garrós, Ana Cristina Calpena, Maria José Rodríguez Lagunas, Francisco Fernández-Campos

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Salima El MoussaouiDepartament de Farmàcia, Tecnologia Farmacèutica i Fisicoquímica, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII 27-31, 08028 Barcelona, Spain.
Mireia MallandrichDepartament de Farmàcia, Tecnologia Farmacèutica i Fisicoquímica, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII 27-31, 08028 Barcelona, Spain.ORCID 0000-0001-9316-8459
Núria GarrósDepartament de Farmàcia, Tecnologia Farmacèutica i Fisicoquímica, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII 27-31, 08028 Barcelona, Spain.
Ana Cristina CalpenaDepartament de Farmàcia, Tecnologia Farmacèutica i Fisicoquímica, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII 27-31, 08028 Barcelona, Spain.ORCID 0000-0002-4989-4821
Maria José Rodríguez LagunasDepartament de Bioquímica i Fisiologia, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII 27-31, 08028 Barcelona, Spain.ORCID 0000-0001-7870-8250
Francisco Fernández-CamposReig-Jofre Laboratories, Av. de les Flors s/n, 08970 Sant Joan Despí, Spain.ORCID 0000-0001-8224-2932
Universitat de Barcelona · ESInstitut de Nanociència i Nanotecnologia de la Universitat de BarcelonaReig Jofre (Spain) · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to different oral and dental conditions, oral mucosa lesions such as those caused by the human papilloma virus and temporomandibular joint pathologies often have to be treated by surgical, ablative or extractive procedures. The treatment and control of pain and inflammation during these procedures is essential to guarantee the patient's well-being. For the foregoing reason, a hydrogel based on sodium alginate and hyaluronic acid containing 2% of ketorolac tromethamine has been developed. We characterized it physically, mechanically and morphologically. The rheological results suggest that the formulation can be easily and gently applied. Ex vivo permeation studies show that Ketorolac Tromethamine is able to penetrate through the buccal and sublingual mucosae, in addition to being retained in the mucosae's structure. Through an in vitro test, we were able to evaluate the role that saliva plays in the bioavailability of the drug, observing that more than half of the applied dose is eliminated in an hour. The histological and cytotoxic studies performed on pigs in vivo showed the excellent safety profile of the formulation, as well as its high tolerability. In parallel, a biomimetic artificial membrane (PermeaPad

Indexed as

Drug Elimination RoutesPapillomaviridaeAdministration, OralAlginatesAnimalsAnti-Inflammatory Agents, Non-SteroidalBiological AvailabilityDrug CompoundingFemaleHumansHyaluronic AcidHydrogelsKetorolac TromethamineMouthMouth MucosaPainAlginatesAnti-Inflammatory Agents, Non-SteroidalHyaluronic AcidHydrogelsKetorolac TromethamineHuman Papilloma Virushyaluronic acidinflammationKetorolacoral condylomapainsodium alginate

Identifiers

PMID34681818
PMCPMC8538847
OpenAlexW3205620459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.